The relationships of age and length of service with job satisfaction: an examination of hotel employees in Thailand S Jalal Sarker, A Crossman, P Chinmeteepituck Journal of managerial Psychology 18 (7), 745-758, 2003 | 390 | 2003 |
Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trial P Schmid, J Abraham, S Chan, D Wheatley, AM Brunt, G Nemsadze, ... Journal of Clinical Oncology 38 (5), 423-433, 2020 | 315 | 2020 |
Phase III, double-blind, randomized trial that compared maintenance lapatinib versus placebo after first-line chemotherapy in patients with human epidermal growth factor … T Powles, RA Huddart, T Elliott, SJ Sarker, C Ackerman, R Jones, ... Journal of Clinical Oncology 35 (1), 48-55, 2017 | 195 | 2017 |
A randomized prospective study comparing acquisition of laparoscopic skills in three‐dimensional (3D) vs. two‐dimensional (2D) laparoscopy B Alaraimi, W El Bakbak, S Sarker, S Makkiyah, A Al‐Marzouq, ... World journal of surgery 38 (11), 2746-2752, 2014 | 177 | 2014 |
A randomised phase 2 study of AZD2014 versus everolimus in patients with VEGF-refractory metastatic clear cell renal cancer T Powles, M Wheater, O Din, T Geldart, E Boleti, A Stockdale, S Sundar, ... European urology 69 (3), 450-456, 2016 | 106 | 2016 |
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). T Powles, A Rodriguez-Vida, I Duran, SJ Crabb, MS Van Der Heijden, ... Journal of Clinical Oncology 36 (15_suppl), 4506-4506, 2018 | 102 | 2018 |
Phase II randomized preoperative window-of-opportunity study of the PI3K inhibitor pictilisib plus anastrozole compared with anastrozole alone in patients with estrogen … P Schmid, SE Pinder, D Wheatley, J Macaskill, C Zammit, J Hu, R Price, ... Journal of Clinical Oncology 34 (17), 1987-1994, 2016 | 94 | 2016 |
Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized … P Schmid, M Zaiss, C Harper-Wynne, M Ferreira, S Dubey, S Chan, ... JAMA oncology 5 (11), 1556-1564, 2019 | 91 | 2019 |
Safety and efficacy of pazopanib therapy prior to planned nephrectomy in metastatic clear cell renal cancer T Powles, N Sarwar, A Stockdale, SJ Sarker, E Boleti, A Protheroe, ... JAMA oncology 2 (10), 1303-1309, 2016 | 88 | 2016 |
Complications of biliary-enteric anastomoses RS Kadaba, KA Bowers, S Khorsandi, RR Hutchins, AT Abraham, ... The Annals of The Royal College of Surgeons of England 99 (3), 210-215, 2017 | 87 | 2017 |
Impact of the new UK licensing law on emergency hospital attendances: a cohort study A Newton, SJ Sarker, GS Pahal, E Van den Bergh, C Young Emergency Medicine Journal 24 (8), 532-534, 2007 | 86 | 2007 |
Accuracy of FAST scan in blunt abdominal trauma in a major London trauma centre S Fleming, R Bird, K Ratnasingham, SJ Sarker, M Walsh, B Patel International Journal of Surgery 10 (9), 470-474, 2012 | 85 | 2012 |
Comparison of 2 extended activities of daily living scales with the Barthel Index and predictors of their outcomes: cohort study within the South London Stroke Register (SLSR) SJ Sarker, AG Rudd, A Douiri, CDA Wolfe Stroke 43 (5), 1362-1369, 2012 | 83 | 2012 |
AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled … P Schmid, J Abraham, S Chan, D Wheatley, M Brunt, G Nemsadze, ... J Clin Oncol 36 (15_suppl), 1007, 2018 | 79 | 2018 |
Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late … P Greaves, SJ Sarker, K Chowdhury, R Johnson, J Matthews, R Matthews, ... British journal of haematology 164 (4), 526-535, 2014 | 66 | 2014 |
A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred … J Shamash, T Powles, SJ Sarker, A Protheroe, N Mithal, R Mills, R Beard, ... British journal of cancer 104 (4), 620-628, 2011 | 61 | 2011 |
Patient-specific prediction of functional recovery after stroke A Douiri, J Grace, SJ Sarker, K Tilling, C McKevitt, CDA Wolfe, AG Rudd International Journal of Stroke 12 (5), 539-548, 2017 | 60 | 2017 |
A multicentre retrospective cohort study of ovarian germ cell tumours: evidence for chemotherapy de-escalation and alignment of paediatric and adult practice C Newton, K Murali, A Ahmad, H Hockings, R Graham, V Liberale, ... European Journal of Cancer 113, 19-27, 2019 | 59 | 2019 |
Incidence of hemorrhagic stroke in black Caribbean, black African, and white populations: the South London stroke register, 1995–2004 NC Smeeton, PU Heuschmann, AG Rudd, AW McEvoy, ND Kitchen, ... Stroke 38 (12), 3133-3138, 2007 | 59 | 2007 |
Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive … GL Johnson, SJ Sarker, F Nannini, A Ferrini, E Taylor, C Lass-Flörl, ... Journal of clinical microbiology 53 (7), 2103-2108, 2015 | 55 | 2015 |